Annual Total Long Term Liabilities
$45.68 M
+$39.60 M+650.61%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual total long term liabilities is $45.68 million, with the most recent change of +$39.60 million (+650.61%) on December 31, 2023.
- During the last 3 years, INZY annual total long term liabilities has risen by +$44.40 million (+3449.49%).
- INZY annual total long term liabilities is now -41.38% below its all-time high of $77.93 million, reached on December 31, 2019.
Performance
INZY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$42.23 M
-$3.52 M-7.70%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly total long term liabilities is $42.23 million, with the most recent change of -$3.52 million (-7.70%) on September 30, 2024.
- Over the past year, INZY quarterly long term liabilities has dropped by -$3.52 million (-7.70%).
- INZY quarterly long term liabilities is now -62.23% below its all-time high of $111.80 million, reached on June 30, 2020.
Performance
INZY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
INZY Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +650.6% | -7.7% |
3 y3 years | +3449.5% | +593.9% |
5 y5 years | -17.0% | +593.9% |
INZY Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1630.4% | -7.7% | +1785.2% |
5 y | 5-year | -41.4% | +3449.5% | -62.2% | -100.0% |
alltime | all time | -41.4% | +3449.5% | -62.2% | -100.0% |
Inozyme Pharma Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $42.23 M(-7.7%) |
Jun 2024 | - | $45.75 M(+0.1%) |
Mar 2024 | - | $45.70 M(+0.0%) |
Dec 2023 | $45.68 M(+650.6%) | $45.68 M(+37.5%) |
Sep 2023 | - | $33.21 M(-0.1%) |
Jun 2023 | - | $33.26 M(+28.6%) |
Mar 2023 | - | $25.87 M(+325.0%) |
Dec 2022 | $6.09 M | $6.09 M(-0.4%) |
Sep 2022 | - | $6.11 M(+172.7%) |
Jun 2022 | - | $2.24 M(-8.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $2.44 M(-7.5%) |
Dec 2021 | $2.64 M(+105.1%) | $2.64 M(-6.7%) |
Sep 2021 | - | $2.83 M(-6.1%) |
Jun 2021 | - | $3.01 M(-5.7%) |
Mar 2021 | - | $3.19 M(+148.2%) |
Dec 2020 | $1.29 M(-98.3%) | $1.29 M(+1.9%) |
Sep 2020 | - | $1.26 M(-98.9%) |
Jun 2020 | - | $111.80 M(>+9900.0%) |
Mar 2020 | - | $0.00(-100.0%) |
Dec 2019 | $77.93 M(+41.6%) | $77.93 M |
Dec 2018 | $55.03 M | - |
FAQ
- What is Inozyme Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Inozyme Pharma?
- What is Inozyme Pharma annual total long term liabilities year-on-year change?
- What is Inozyme Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Inozyme Pharma?
- What is Inozyme Pharma quarterly long term liabilities year-on-year change?
What is Inozyme Pharma annual total long term liabilities?
The current annual total long term liabilities of INZY is $45.68 M
What is the all time high annual total long term liabilities for Inozyme Pharma?
Inozyme Pharma all-time high annual total long term liabilities is $77.93 M
What is Inozyme Pharma annual total long term liabilities year-on-year change?
Over the past year, INZY annual total long term liabilities has changed by +$39.60 M (+650.61%)
What is Inozyme Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of INZY is $42.23 M
What is the all time high quarterly long term liabilities for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total long term liabilities is $111.80 M
What is Inozyme Pharma quarterly long term liabilities year-on-year change?
Over the past year, INZY quarterly total long term liabilities has changed by -$3.52 M (-7.70%)